Description

A study by StrategyHelix indicates that the global formulation development outsourcing market is expected to increase by US$ 8.3 billion from 2022 to 2028, garnering a CAGR of 7.1% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for formulation development outsourcing. The global formulation development outsourcing market is segmented on the basis of service, dosage form, application, end user, and region. Based on service, the global formulation development outsourcing market is categorized into formulation optimization, pre-formulation services. On the basis of dosage form, the global formulation development outsourcing market has been segmented into inhaled, injectable, oral, topical, others. By application, the global formulation development outsourcing market has been segmented into cardiovascular, genetic disorders, infectious diseases, neurology, oncology, respiratory, others. Based upon end user, the global formulation development outsourcing market is categorized into government and academic institutes, pharmaceutical and biopharmaceutical companies. In terms of geography, the global formulation development outsourcing market has been segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global formulation development outsourcing market is highly competitive. As of 2021, the major players in the global formulation development outsourcing market were Aizant Drug Research Solutions Private Limited, Biocon Limited (Syngene International Limited), Catalent Inc., Charles River Laboratories International Inc., Emergent BioSolutions Inc., Intertek Group plc, IRISYS LLC, Laboratory Corporation of America Holdings (LabCorp), Lonza Group AG, PCI Pharma Services Inc. (PCI), Piramal Enterprises Ltd, Quotient Sciences Limited, Thermo Fisher Scientific Inc. (Patheon N.V.).

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the formulation development outsourcing market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Service: formulation optimization, pre-formulation services
Dosage form: inhaled, injectable, oral, topical, others
Application: cardiovascular, genetic disorders, infectious diseases, neurology, oncology, respiratory, others
End user: government and academic institutes, pharmaceutical and biopharmaceutical companies
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global formulation development outsourcing market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Formulation development outsourcing market overview
Part 3. Market breakdown by service
– Formulation optimization
– Pre-formulation services
Part 4. Market breakdown by dosage form
– Inhaled
– Injectable
– Oral
– Topical
– Others
Part 5. Market breakdown by application
– Cardiovascular
– Genetic disorders
– Infectious diseases
– Neurology
– Oncology
– Respiratory
– Others
Part 6. Market breakdown by end user
– Government and academic institutes
– Pharmaceutical and biopharmaceutical companies
Part 7. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 8. Key companies
– Aizant Drug Research Solutions Private Limited
– Biocon Limited (Syngene International Limited)
– Catalent Inc.
– Charles River Laboratories International Inc.
– Emergent BioSolutions Inc.
– Intertek Group plc
– IRISYS LLC
– Laboratory Corporation of America Holdings (LabCorp)
– Lonza Group AG
– PCI Pharma Services, Inc. (PCI)
– Piramal Enterprises Ltd
– Quotient Sciences Limited
– Thermo Fisher Scientific Inc. (Patheon N.V.)
About StrategyHelix
Disclaimer